Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases › Research Explorer

DOI

https://doi.org/10.1136/rmdopen-2021-002035
Final published version

Laura Boekel
Femke Hooijberg
Yaëlle R. Besten
Maureen Leeuw
Sadaf Atiqi
Carla A. Wijbrandts
Martijn Gerritsen
C. Krieckaert
Bas Dijkshoorn
Siham Bakhlakh
Juliette J. Crooijmans
Alexandre Voskuyl
Irene E. van der Horst-Bruinsma
Willem Lems
Pj Koos van Dam
Maurice Steenhuis
Sofie Keijzer
Olvi Cristianawati
Jim Keijser
Floris C. Loeff
Maarten Boers

Original language	English
Article number	002035
Journal	RMD open
Volume	8
Issue number	1
DOIs	https://doi.org/10.1136/rmdopen-2021-002035
Publication status	Published - 5 Apr 2022

Research areas

COVID-19, antirheumatic agents, autoimmune diseases, biological therapy, epidemiology

ID: 23050825